Recurrent thrombosis is the hallmark of the antiphospholipid syndrome (APS). Pregnancy
losses and cytopenias (thrombocytopenia or hemolytic anemia) may occur as the sole …

The antiphospholipid antibody syndrome (APS) is recognized as a major cause of acquired
thrombophilia and recurrent pregnancy morbidity. 6, 9, 11, 12, 19 It can either occur as a free …

The presence of antiphospholipid antibodies has been shown to be related to an increased
risk of thrombotic events. In patients with definite antiphospholipid syndrome (APS), that is …

Abstract Purpose of the Review To review the available evidence on the management of a
variety of non-criteria manifestations in antiphospholipid syndrome (APS), including valvular …

The antiphospholipid syndrome (APS) is defined by venous or arterial thrombosis and/or
pregnancy morbidity in patients with persistent presence of antiphospholipid antibodies …

Antiphospholipid syndrome (APS) is an autoimmune disease characterised by vascular
thrombosis and/or pregnancy morbidity in the presence of persistently positive serum tests …

Antiphospholipid syndrome (APS) is a clinico-serologic diagnosis. The two main clinical
subtypes are thrombotic APS and obstetric APS. APS is suspected when thrombosis, arterial …

Antiphospholipid antibodies (aPLs) are associated with arterial and venous thrombosis,
recurrent pregnancy loss and thrombocytopenia. Although aPLs have not yet been …

The Antiphospholipid syndrome (APS), formerly known as Anticardiolipin or Hughes
syndrome, is a systemic autoimmune disorder characterized by obstetrical complications …

The antiphospholipid syndrome (APS) is defined by the occurrence of venous and arterial
thromboses, often multiple, and recurrent fetal losses, frequently accompanied by a …